Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:491-496

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grundy, S. M.
Right arrow Articles by Friedman, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grundy, S. M.
Right arrow Articles by Friedman, L. M.
Related Collections
Right arrow Secondary prevention
Right arrow Restenosis
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology

(Circulation. 2001;104:491.)
© 2001 American Heart Association, Inc.


Current Perspectives

Cardiovascular Risk Assessment Based on US Cohort Studies

Findings From a National Heart, Lung, and Blood Institute Workshop

Scott M. Grundy, MD, PhD; Ralph B. D’Agostino, Sr, PhD; Lori Mosca, MD, PhD, MPH; Gregory L. Burke, MD; Peter W.F. Wilson, MD; Daniel J. Rader, MD; James I. Cleeman, MD; Edward J. Roccella, PhD; Jeffrey A. Cutler, MD; Lawrence M. Friedman, MD

From the Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas (S.M.G.); Framingham Heart Study, Boston University, Boston, Mass (R.B.D., P.W.F.W.); Preventive Cardiology, Columbia and Cornell Universities, New York, NY (L.M.); Wake Forest School of Medicine, Winston-Salem, NC (G.B.); Preventive Cardiology and Lipid Research Center, University of Pennsylvania Health System, Philadelphia (D.R.); and Office of Prevention, Education, and Control (J.I.C., E.R.), Division of Epidemiology and Clinical Applications (J.C.), and Office of the Director (L.F.), National Heart, Lung, and Blood Institute, Bethesda, Md.

Correspondence to Jeffrey A. Cutler, MD, National Heart, Lung, and Blood Institute, 6701 Rockledge Dr, Bethesda, MD 20892-7936. E-mail cutlerj@nhlbi.nih.gov


Key Words: cardiovascular diseases • coronary disease • risk factors • epidemiology


*    Introduction
 
This report was derived from a workshop on cardiovascular risk assessment sponsored by the National Heart, Lung, and Blood Institute, which addressed whether risk equations developed in the Framingham Heart Study (FHS) for predicting new-onset coronary heart disease (CHD) apply to diverse population groups. Preparation for the workshop included a reanalysis and comparison of prospective studies in several different populations in which risk factors were related to cardiovascular outcomes. Some studies included fatal and nonfatal CHD end points, whereas others contained only CHD mortality. Extensive collaboration provided as much uniformity as possible with respect to both risk factors and CHD end points.

The FHS has led in defining the quantitative impact of risk factors.1 Many potential risk factors were measured and related to cardiovascular outcomes. Several risk factors proved to be strong, largely independent predictors of cardiovascular disease (CVD). These factors—advancing age, cigarette smoking, blood pressure (particularly systolic), cholesterol in total serum and HDL, and diabetes—served as the basis for the development of risk prediction equations.1

If FHS risk estimates are to be widely used, they must apply widely in the US population. To document their transportability, they must be compared with prospective studies in other populations. Although the FHS is the longest running prospective study, there are other major studies. The cardiovascular end points of these other studies have varied. Some include cardiovascular morbidity and mortality; others have only cardiovascular mortality. Among the end points, CHD is the most extensively reported; for this reason, CHD was the primary focus . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. Baumgart, V. Klauss, F. Baer, F. Hartmann, H. Drexler, W. Motz, H. Klues, S. Hofmann, W. Volker, T. Pfannebecker, et al.
One-Year Results of the SCORPIUS Study: A German Multicenter Investigation on the Effectiveness of Sirolimus-Eluting Stents in Diabetic Patients
J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1627 - 1634.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Nasir, M. J. Budoff, N. D. Wong, M. Scheuner, D. Herrington, D. K. Arnett, M. Szklo, P. Greenland, and R. S. Blumenthal
Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA)
Circulation, August 7, 2007; 116(6): 619 - 626.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Wu, X. Liu, X. Li, Y. Li, L. Zhao, Z. Chen, Y. Li, X. Rao, B. Zhou, R. Detrano, et al.
Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults
Circulation, November 21, 2006; 114(21): 2217 - 2225.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
D. P. Ritzwoller, D. Toobert, A. Sukhanova, and R. E. Glasgow
Economic analysis of the mediterranean lifestyle program for postmenopausal women with diabetes.
The Diabetes Educator, September 1, 2006; 32(5): 761 - 769.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. A. Mittleman
A 39-year-old woman with hypercholesterolemia.
JAMA, July 19, 2006; 296(3): 319 - 326.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation, June 20, 2006; 113(24): e873 - e923.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke, June 1, 2006; 37(6): 1583 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Ann Fam MedHome page
R. E. Goldman, D. R. Parker, C. B. Eaton, J. M. Borkan, R. Gramling, R. T. Cover, and D. K. Ahern
Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies
Ann. Fam. Med, May 1, 2006; 4(3): 205 - 212.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. S. Karlamangla, B. H. Singer, and T. E. Seeman
Reduction in Allostatic Load in Older Adults Is Associated With Lower All-Cause Mortality Risk: MacArthur Studies of Successful Aging
Psychosom Med, May 1, 2006; 68(3): 500 - 507.
[Abstract] [Full Text] [PDF]


Home page
BiostatisticsHome page
T. Cai, M. S. Pepe, Y. Zheng, T. Lumley, and N. S. Jenny
The sensitivity and specificity of markers for event times
Biostat., April 1, 2006; 7(2): 182 - 197.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. Yang, L. D. Botto, J. D. Erickson, R. J. Berry, C. Sambell, H. Johansen, and J.M. Friedman
Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
Circulation, March 14, 2006; 113(10): 1335 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
M. GLICK and B. L. GREENBERG
The potential role of dentists in identifying patients' risk of experiencing coronary heart disease events
J Am Dent Assoc, November 1, 2005; 136(11): 1541 - 1546.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Dibra, A. Kastrati, J. Mehilli, J. Pache, H. Schuhlen, N. von Beckerath, K. Ulm, R. Wessely, J. Dirschinger, A. Schomig, et al.
Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients
N. Engl. J. Med., August 18, 2005; 353(7): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Rhoades
Racial Misclassification and Disparities in Cardiovascular Disease Among American Indians and Alaska Natives
Circulation, March 15, 2005; 111(10): 1250 - 1256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. Sies, T. Schewe, C. Heiss, and M. Kelm
Cocoa polyphenols and inflammatory mediators
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 304S - 312S.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Jain, R. Peshock, D. K. McGuire, D. Willett, Z. Yu, G. L. Vega, R. Guerra, H. H. Hobbs, S. M. Grundy, and the Dallas Heart Study Investigators
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study
J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1011 - 1017.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Eyre, R. Kahn, R. M. Robertson, and and the ACS/ADA/AHA Collaborative Writing Committe
Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
Stroke, August 1, 2004; 35(8): 1999 - 2010.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
H. Eyre, R. Kahn, R. M. Robertson, and the ACS/ADA/AHA Collaborative Writing Committe, N. G. Clark, C. Doyle, T. Gansler, T. Glynn, Y. Hong, R. A. Smith, et al.
Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
CA Cancer J Clin, July 1, 2004; 54(4): 190 - 207.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. Eyre, R. Kahn, and R. M. Robertson
Preventing Cancer, Cardiovascular Disease, and Diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
Diabetes Care, July 1, 2004; 27(7): 1812 - 1824.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Eyre, R. Kahn, R. M. Robertson, the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Member, N. G. Clark, C. Doyle, Y. Hong, T. Gansler, T. Glynn, et al.
Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association
Circulation, June 29, 2004; 109(25): 3244 - 3255.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Expert Panel/Writing Group, L. Mosca, L. J. Appel, E. J. Benjamin, K. Berra, N. Chandra-Strobos, R. P. Fabunmi, D. Grady, C. K. Haan, S. N. Hayes, et al.
Evidence-based guidelines for cardiovascular disease prevention in women
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 900 - 921.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Mosca, L. J. Appel, E. J. Benjamin, K. Berra, N. Chandra-Strobos, R. P. Fabunmi, D. Grady, C. K. Haan, S. N. Hayes, D. R. Judelson, et al.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): e29 - 50.
[Full Text]


Home page
CirculationHome page
L. Mosca, L. J. Appel, E. J. Benjamin, K. Berra, N. Chandra-Strobos, R. P. Fabunmi, D. Grady, C. K. Haan, S. N. Hayes, D. R. Judelson, et al.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Circulation, February 10, 2004; 109(5): 672 - 693.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
I. M. van der Meer, M. P. M. de Maat, A. J. Kiliaan, D. A. M. van der Kuip, A. Hofman, and J. C. M. Witteman
The Value of C-Reactive Protein in Cardiovascular Risk Prediction: The Rotterdam Study
Arch Intern Med, June 9, 2003; 163(11): 1323 - 1328.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
N. Engl. J. Med., November 14, 2002; 347(20): 1557 - 1565.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. S.V. Elkind, R. Sciacca, B. Boden-Albala, S. Homma, and M. R. Di Tullio
Leukocyte Count Is Associated With Aortic Arch Plaque Thickness
Stroke, November 1, 2002; 33(11): 2587 - 2592.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. M. Spooner and D. P. Zipes
Sudden Death Predictors: An Inflammatory Association
Circulation, June 4, 2002; 105(22): 2574 - 2576.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Tanaka, D. R. Seals, K. D. Monahan, C. M. Clevenger, C. A. DeSouza, and F. A. Dinenno
Regular aerobic exercise and the age-related increase in carotid artery intima-media thickness in healthy men
J Appl Physiol, April 1, 2002; 92(4): 1458 - 1464.
[Abstract] [Full Text] [PDF]